Brief: Cytodyn - FDA Grants Emergency Ind For Two Coronavirus Patients Treated In New York With Cytodyn’S Leronlimab
19/03/2020 10:18
March 19 (Reuters) - Cytodyn Inc CYDY.PK :
* U.S. FOOD AND DRUG ADMINISTRATION (FDA) GRANTS EMERGENCY
IND FOR
TWO CORONAVIRUS PATIENTS TREATED IN NEW YORK WITH CYTODYN’S
LERONLIMAB
Source text for Eikon: ID:nGNX5SRFX
Further company coverage: CYDY.PK
((Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer